Abstract: In ␣1, ␤2, and ␥2 subunits of the ␥-aminobutyric acid A (GABA A ) receptor, a conserved lysine residue occupies the position in the middle of the predicted extracellular loop between the transmembrane M2 and M3 regions. In all three subunits, this residue was mutated to alanine. Whereas the mutation in ␣1 and ␤2 subunits resulted each in about a sixfold shift of the concentration-response curve for GABA to higher concentrations, no significant effect by mutation in the ␥ subunit was detected. The affinity for the competitive inhibitor bicuculline methiodide was not affected by the mutations in either the ␣1 subunit or the ␤2 subunit. Concentration-response curves for channel activation by pentobarbital were also shifted to higher concentrations by the mutation in the ␣ and ␤ subunits. Binding of [ 3 H]Ro 15-1788 was unaffected by the mutation in the ␣ subunit, whereas the binding of [ 3 H]muscimol was shifted to lower affinity. Mutation of the residue in the ␣1 subunit to E, Q, or R resulted in an about eight-, 10-, or fivefold shift, respectively, to higher concentrations of the concentration-response curve for GABA. From these observations, it is concluded that the corresponding residues on the ␣1 and ␤2 subunits are involved more likely in the gating of the channel by GABA than in the binding of GABA or benzodiazepines. Key Words: GABA A receptor-Channel gating-GABA-Bicuculline -Ion channel.
The ␥-aminobutyric acid A (GABA A ) receptor is one of the major inhibitory neuronal ion channels in mammalian central nervous system. Two subunits were purified initially (Sigel et al., 1983) , and their coding DNA has been cloned (Schofield et al., 1987) . Multiple mammalian subunits have been cloned in the meantime (for reviews, see Macdonald and Olsen, 1994; Rabow et al., 1995) . These subunits show extensive homology to subunits of the receptors for acetylcholine (nicotinic type), glycine, and serotonin (type 3).
The GABA A receptor is the site of action of benzodiazepines and related compounds (for review, see Sieghart, 1995) . Amino acid residues located on both the ␤ and ␣ subunits are important for the interaction with the channel agonist GABA (Sigel et al., 1992; Amin and Weiss, 1993; Smith and Olsen, 1994; Westh-Hansen et al., 1997) . Amino acid residues located on both the ␣ and ␥ subunits are involved in the interaction with ligands of the benzodiazepine binding site (Pritchett and Seeburg, 1991; Wieland et al., 1992; Buhr et al., 1996 Buhr et al., , 1997a Amin et al., 1997; Buhr and Sigel, 1997; Wingrove et al., 1997; Schaerer et al., 1998; Sigel et al., 1998) . The agonist binding site of the channel is located at subunit interfaces in a homologous position to the allosteric site occupied by ligands of the benzodiazepine binding site (for reviews, see Galzi and Changeux, 1994; Sigel and Buhr, 1997) .
Amino acid residues located in the putative transmembrane segment M2, which lines the ion pore, have been implicated in channel gating of the GABA A receptor. In this work, we studied the role of the conserved lysine residues in the middle of the predicted loop between the transmembrane stretches M2 and M3 in ␣1, ␤2, and ␥2 subunits for the interaction of the GABA A receptor with its agonist and with ligands of the benzodiazepine binding site.
MATERIALS AND METHODS

Construction of receptor subunits
The cDNAs coding for the ␣1, ␤2, and ␥2S subunits of the rat GABA A receptor channel have been described elsewhere (Lolait et al., 1989; Malherbe et al., 1990a,b) . The mutants were prepared using the QuikChange mutagenesis kit (Stratagene). In vitro synthesized sequences have been verified by DNA sequencing. For cell transfection, the cDNAs were subcloned into the polylinker of pBC/CMV. This expression vector allows a high-level expression of a foreign gene under control of the cytomegalovirus promoter and an SP6 promoter for in vitro transcription. The ␣ subunit was cloned into the EcoRI
Expression and functional characterization
Xenopus laevis oocytes were prepared, injected, and defolliculated and currents were recorded as described (Sigel, 1987; Sigel et al., 1990) . In brief, oocytes were injected with 50 nl of cRNA dissolved in 5 mM K-HEPES, pH 6.8. This solution contained the transcripts coding for the different subunits at a concentration of 10 nM for ␣1, 10 nM for ␤2, and 50 nM for ␥2. RNA transcripts were synthesized from linearized plasmids encoding the desired protein using the message machine kit (Ambion) according to the recommendation of the manufacturer. A poly(A) tail of ϳ300 residues was added to the transcripts by using yeast poly(A) polymerase (USB or Amersham). The cRNA combinations were coprecipitated in ethanol and stored at Ϫ20°C. Transcripts were quantified on agarose gels after staining with Radiant Red RNA Stain (Bio-Rad) by comparing staining intensities with various amounts of molecular weight markers (RNA Ladder, GibcoBRL). Electrophysiological experiments were performed by the two-electrode voltage-clamp method at a holding potential of Ϫ80 mV. The medium contained 90 mM NaCl, 1 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2 , and 10 mM Na-HEPES, pH 7.4. GABA was applied for 20 s, and a washout period of 4 min was allowed to ensure full recovery from desensitization. The perfusion system was cleaned between drug applications by washing with dimethyl sulfoxide to avoid contamination.
Concentration-response curves for GABA with a single apparent component were fitted with the equation
, where c is the concentration of GABA, EC 50 the concentration of GABA eliciting half-maximal current amplitude, I max the maximal current amplitude, I the current amplitude, and n the Hill coefficient. Inhibition curves for bicuculline were fitted with the equation I(c) ϭ I(0)/ [1 ϩ (IC 50 /c)], where c is the concentration of bicuculline methiodide, I(0) the current in the absence of bicuculline methiodide, and IC 50 the concentration of bicuculline causing 50% inhibition of the current. Data are given as means Ϯ SEM (number of experiments, number of batches of oocytes).
Transfection of recombinant GABA A receptor in cultured cells
The cells were maintained in minimum essential medium (GibcoBRL) supplemented with 10% fetal calf serum, 2 mM glutamine, 50 units/ml penicillin, and 50 g/ml streptomycin by standard cell culture techniques. Equal amounts (total of 20 g of DNA per 90-mm dish) of GABA receptor subunits were transfected into human embryonic kidney (HEK) 293 cells (ATCC, no. CRL 1573) by the calcium phosphate precipitation method (Chen and Okayama, 1987) . After overnight incubation, the cells were washed twice with serum-free medium and refed with medium.
Membrane preparation
Approximately 60 h after transfection, the cells were harvested by washing with ice-cold phosphate-buffered saline, pH 7.0 (130 mM NaCl, 16 mM disodium hydrogen phosphate, 4 mM potassium dihydrogen phosphate) and centrifuged at 150 g. Cells were washed with buffer containing 10 mM potassium phosphate, 100 mM KCl, 0.1 mM K-EDTA, pH 7.4. Cells were homogenized by sonication in the presence of 10 M phenylmethylsulfonyl fluoride and 1 mM EDTA. Membranes were collected by three centrifugation-resuspension cycles (100,000 g for 20 min) and then used for ligand binding or stored at Ϫ20°C.
Binding assays
Resuspended membranes (0.5 ml) obtained from cells transfected with wild-type or mutated receptors were incubated for 90 min on ice in the presence of [ 3 H]flumazenil (87 Ci/mmol) or [
3 H]muscimol (both from DuPont-New England Nuclear). Membranes (20 -50 g of protein per filter) were collected by rapid filtration on GF/C filters presoaked in 0.3% polyethylenimine. After three washing steps with 4 ml of buffer, the filter-retained radioactivity was determined by liquid scintillation counting. Nonspecific binding was measured in the presence of 10 M unlabeled flumazenil or 200 M muscimol, respectively. Protein concentration was determined with the Bio-Rad protein assay kit (Bio-Rad) with bovine serum albumin as standard. Figure 1 shows an alignment of ␣, ␤, and ␥ subunits of the region between the putative transmembrane segments M2 and M3 with the conserved lysine residue of interest. ␣1␤2␥2, ␣1(K278A)␤2␥2, ␣1␤2(K275A)␥2, ␣1␤2␥2(K289A), ␣1(K278A)␤2(K275A)␥2(K289A), ␣1(K278E)␤2␥2, ␣1(K278Q)␤2␥2, and ␣1(K278R)-␤2␥2 GABA A receptors were expressed in Xenopus oocytes in a functionally active form, and electrophysiological experiments were carried to characterize this function. All receptors resulted in the expression of microampere-sized chloride currents upon exposure to the agonist GABA. The receptors containing a single mutant subunit expressed about half of the maximal current amplitude as compared with wild-type receptors. Receptors containing all three mutated subunits expressed ϳ10 times less current than wild-type receptors. The same amount of cRNA was injected in each case. It is not clear from these data whether a decrease in whole-cell current is due to an altered number of expressed channels, to an altered single-channel conductance, or to an altered open probability. In the light of our data presented below, we favor the last possibility. ␣1␤2␥2 and ␣1(K278A)␤2␥2 GABA A receptors were also expressed in HEK 293 cells for binding studies. Figure 2 compares GABA concentration-response curves for wild-type and alanine mutant GABA receptors containing either one or three mutated subunits. Mutation of the conserved lysine residue in the middle of the FIG. 1. Alignment of the amino acid sequences between the putative transmembrane segments M2 and M3 of rat ␣1, ␤2, and ␥2 subunits. The investigated homologous residues are shown in bold face. An asterisk denotes a conserved residue in all three subunits, and a plus sign a conserved residue in two subunits.
RESULTS
region of interest to alanine resulted in the case of either the mutated ␣ or the ␤ subunit in an about sixfold shift to higher concentrations. In contrast, the mutation in the ␥ subunit caused no significant effect. The EC 50 in wild-type receptors was 26 Ϯ 9 M (n ϭ 5, three batches of oocytes), whereas it was increased to 167 Ϯ 16 M (n ϭ 5, two batches of oocytes), 149 Ϯ 20 M (n ϭ 4, two batches of oocytes), and 33 Ϯ 10 M (n ϭ 4, two batches of oocytes) in receptors carrying a mutated ␣, ␤, or ␥ subunit, respectively. The Hill coefficient n of the concentration-response curve was somewhat decreased by the mutations in the ␣ or the ␤ subunit. It amounted to 1.39 Ϯ 0.07 (n ϭ 5) for the wild-type receptor and 1.11 Ϯ 0.01 (n ϭ 5), 1.15 Ϯ 0.07 (n ϭ 4), and 1.22 Ϯ 0.09 (n ϭ 4) for the three mutant receptors. Combined expression of all three mutated subunits resulted in an ϳ19-fold shift in the concentration-response curve with an EC 50 of 484 Ϯ 122 M (n ϭ 3), showing an additional effect beyond a single mutation, when fitted with a single EC 50 . The Hill coefficient was, however, at 0.89 Ϯ 0.07 lower than for channels carrying single mutations, indicating the possible existence of more than one component. Therefore, data were fitted with two components. Best fit was obtained with EC 50 values of 229 Ϯ 34 M (n ϭ 3) and 3,220 Ϯ 2,130 M (n ϭ 3) and Hill coefficients of ϳ1.26 and ϳ0.73, the two components amounting to 63 and 37%, respectively. It is not clear whether the two components are due to a heterogeneous receptor population or due to two distinct sites on a single receptor.
The presently favored stoichiometry of the receptor is 2␣2␤1␥. Therefore, ␣1␤2␥2(K289A) may contain one mutated subunit, ␣1(K278A)␤2␥2 and ␣1␤2(K275A)␥2 two mutated subunits, and ␣1(K278A)␤2(K275A)-␥2(K289A) five mutated subunits. The fact that ␣1␤2␥2(K289A) induces a much smaller shift may be thought to reflect this stoichiometry. In fact, if each mutated subunit in a receptor causes an additive threefold shift in the concentration-response curve, all data but those from ␣1␤2␥2(K289A) may be explained. In the latter case, a much smaller shift was observed.
The electrically positively charged lysine residue in the ␣ subunit was also mutated to the positively charged arginine, to the electrically neutral glutamine, and to the negatively charged glutamic acid. These three point mutations resulted in a five-, 10-, and eightfold shift to lower concentrations in the concentration-response curves, respectively (Fig. 3) . Best fit was obtained with EC 50 values of 120 Ϯ 9 M (n ϭ 3, two batches of oocytes), 271 Ϯ 64 M (n ϭ 3, two batches of oocytes), and 214 Ϯ 7 M (n ϭ 3, two batches of oocytes) and Hill coefficients of about 0.9, 1.0, and 1.0, respectively. Desensitization as visible in Xenopus oocytes was not obviously affected by all the investigated mutations.
Concentration-response curves for ␣1␤2␥2 and ␣1(K278A)␤2␥2 with muscimol as the agonist revealed a shift to lower concentrations in the mutant receptor similar to those with GABA as the agonist (data not shown).
At high concentrations, pentobarbital is able to induce channel opening in the absence of GABA. Concentration-response curves for ␣1␤2␥2, ␣1(K278A)␤2␥2, ␣1␤2(K275A)␥2, ␣1␤2␥2(K289A), and ␣1(K278A)-␤2(K275A)␥2(K289A) revealed a biphasic curve in all cases. Whereas there was induction of current at moderate concentrations of pentobarbital, at very high concentrations of pentobarbital the amplitude was reduced again (Fig. 4) . However, it was evident that the mutations in the ␣ subunit and the ␤ subunit induced a shift of the activation of the current to higher concentrations. For receptors consisting of mutated subunits only [␣1(K278A)␤2(K275A)␥2(K289A)], the apparent shift was even larger (Fig. 4).   FIG. 3 . Effect of the point mutations of the lysine residue K278 of the ␣ subunit [wild-type (F)] to alanine (E), glutamine (OE), glutamic acid (), or arginine (s). cRNA-injected Xenopus oocytes were held at Ϫ80 mV under two-electrode voltage clamp. Increasing concentrations of GABA were superfused for 20 s. Data were normalized for each curve to give a maximal current amplitude of 100% and subsequently averaged. Data are given as means Ϯ SEM.
FIG. 2.
GABA concentration-response curves for the wild-type receptor (F), and lysine to alanine mutated ␣1(K278A)␤2␥2 (E), ␣1␤2(K275A)␥2 (ᮀ), ␣1␤2␥2(K289A) (‚), and ␣1(K278A)-␤2(K275A)␥2(K289A) (ƒ) receptors. cRNA-injected Xenopus oocytes were held at Ϫ80 mV under two-electrode voltage clamp. Increasing concentrations of GABA were superfused for 20 s. Data were normalized for each curve to give a maximal current amplitude of 100% and subsequently averaged. Data are given as means Ϯ SEM.
To see whether the competitive antagonist sensitivity of the channel was also affected by the mutations, inhibition curves of the current elicited by GABA with bicuculline methiodide were carried out. First, the GABA concentration eliciting ϳ10% of the maximal current amplitude was established. Subsequently, this concentration of GABA was coapplied with increasing concentrations of bicuculline methiodide. Wild-type receptors and receptors containing a single mutated ␣ or ␤ subunit were inhibited with IC 50 values of 1.8 Ϯ 0.4 M (n ϭ 3), 1.9 Ϯ 0.9 M (n ϭ 3), and 1.0 Ϯ 0.1 M (n ϭ 4), respectively (Fig. 5) . This demonstrates that the inhibitory potency for competitive antagonists is not decreased by the mutations. This would be expected if channel gating, but not the binding site for agonists and competitive antagonists, is affected. To analyze this inhibition in more detail, a Schild plot analysis of this inhibition in wild-type and ␣ subunit mutant channels was carried out (Fig. 6 ). For this purpose, concentrationresponse curves for GABA were carried out in the presence of different concentrations of bicuculline methiodide. Analysis was difficult because of the high concentrations of GABA needed, especially for the mutant channels, which limited the useful concentration range of bicuculline. It should be pointed out that these high concentrations of agonist led to an increase in ionic strength and osmolarity of the medium. At the highest ligand concentration, this increase in osmolarity was from 203 to 323 mOsmol. For wild-type and mutant channels, the slope of the linear fit was near 1, as expected for a competitive inhibitor. Therefore, the final fit was made with a fixed slope equal to 1.0. The binding affinity of bicuculline was determined to be 2-5 M for both wild-type and mutant receptors. As far as the analysis could be carried out with the mutant channel, it confirms that at least in the case of the mutation in ␣ subunits the antagonist affinity does not seem to be affected.
The interaction with benzodiazepine binding site ligands was also tested. The ability of diazepam to stimulate GABA responses was not decreased in all ␣-mutant channels as compared with wild-type channels (data not shown). The inhibitory effects of the partial negative allosteric modulator Ro 15-4513 were also unaffected by   FIG. 4 . Pentobarbital concentration-response curves for the wild-type receptor (F), and mutant ␣1(K278A)␤2␥2 (E), ␣1␤2(K275A)␥2 (ᮀ), ␣1␤2␥2(K289A) (‚), and ␣1(K278A)-␤2(K275A)␥2(K289A) (ƒ) receptors. cRNA-injected Xenopus oocytes were held at Ϫ80 mV under two-electrode voltage clamp. Increasing concentrations of pentobarbital were superfused for 20 s. Data were normalized for each curve to give a current amplitude elicited by 10 mM GABA of 100% and subsequently averaged. Data are given as means Ϯ SEM of three to five experiments each.
FIG. 5. Inhibition of wild-type receptor (F) and ␣1(K278A)␤2␥2
(E) and ␣1␤2(K275A)␥2 (ᮀ) mutant receptors by bicuculline methiodide. cRNA-injected Xenopus oocytes were held at Ϫ80 mV under two-electrode voltage clamp. Increasing concentrations of bicuculline methiodide were superfused for 20 s in combination with a fixed concentration of GABA eliciting ϳ10% of the maximal current amplitude. Data were normalized for each curve to give a current amplitude of 100% in the absence of bicuculline methiodide and subsequently averaged. Data are given as means Ϯ SEM.
FIG. 6.
Schild plot of the inhibition by bicuculline methiodide wild-type (F) and mutant ␣1(K278A)␤2␥2 (E) receptors. cRNAinjected Xenopus oocytes were held at Ϫ80 mV under twoelectrode voltage clamp. Increasing concentrations of GABA were superfused for 20 s. Data were normalized for each curve to give a maximal current amplitude of 100% and subsequently averaged. The same experiment was carried out in the presence of 15, 60, and 240 M bicuculline methiodide for wild-type receptors and 5, 15, 30, and 60 M bicuculline methiodide for mutant receptors. Data are given as means Ϯ SEM. They were fitted with a straight line of slope 1. Fits for the wild-type and the mutant receptor overlap.
the alanine mutations in ␣ and ␤ subunits. The binding affinity of [
3 H]Ro 15-1788 to receptors expressed in HEK 293 cells was not affected significantly by the alanine mutation in the ␣ subunit (Fig. 7) . Maximal binding was reduced to 57% in this experiment and to 68% in a second experiment. Whether biosynthesis in HEK 293 cells is slightly reduced is not clear from these findings, as expression levels vary quite strongly upon transfection. The binding affinity for [
3 H]muscimol was strongly decreased by the same mutation, such that a binding study was not feasible (data not shown). A decrease in agonist affinity in binding experiments can occur as a consequence of altered binding, but also as a consequence of altered gating properties (Colquhoun, 1998) .
DISCUSSION
We investigated the role of the conserved lysine residue in the middle of the region between the putative transmembrane segments M2 and M3 in ␣, ␤, and ␥ subunits for two reasons. First, photoaffinity labeling using Ro 15-4513 marked a peptide putatively corresponding to the region between M1 and M3 in the ␣ subunit . The binding site for ligands of the benzodiazepine binding site is thought to be homologous to the GABA binding site and homologous to the agonist binding site in nicotinic acetylcholine receptors, which is thought to be at ϳ30 Å distance from the membrane bilayer (Unwin, 1993) . We therefore suspected a chemically reactive residue at maximal potential extracellular distance from the membrane to interact with Ro 15-4513. In the middle between M2 and M3 such a residue is located, the lysine residue in question. Second, upon mutation of the homologous residue in the subunit, an altered gating behavior of the resulting homomeric channels was described, specifically an increase in the Hill coefficient of the agonist concentration-response curve (Kusama et al., 1994) .
We mutated this conserved lysine residue in ␣, ␤, and ␥ subunits to alanine and expressed channels carrying an individual mutation. These point mutations had no effect on the binding affinity of the benzodiazepine antagonist Ro 15-1788, the current stimulation by diazepam, or the current inhibition by Ro 15-4513. Instead, mutations in the ␣ and ␤ subunits, but not the mutation in the ␥ subunit, strongly shift the concentration-response curves for GABA to higher concentrations. It is interesting to note that ␣ and ␤ subunits contribute to the binding site for the channel agonist GABA (Sigel et al., 1992; Amin and Weiss, 1993; Smith and Olsen, 1994; Westh-Hansen et al., 1997) . The following observations indicate, however, that the gating of the channels may be affected rather than the binding site for the agonist GABA. The IC 50 for the competitive antagonist bicuculline methiodide for the inhibition of current elicited by GABA was decreased rather than increased, at least for the mutation in the ␤ subunit. A Schild analysis indicated little alteration of the binding affinity of bicuculline methiodide upon mutation of the ␣ subunit. The fact that the binding of this competitive antagonist is not affected by the mutation is indicative of an unaltered binding site for agonists and of an effect of these mutations on conformational changes occurring as a consequence of this binding that ultimately lead to channel opening. The maximal current amplitude of receptors containing all three mutated subunits was ϳ10 times smaller than that of wild-type receptors. This could be due to a decreased biosynthesis, assembly, or surface integration. But it is tempting to speculate that in this case the efficacy of the channel opening is decreased. The homologous mutation in 1 receptors led to an increase in the Hill coefficient of the concentration-response curve. Such an increase could be expected here. We observed rather a decrease in this parameter upon the mutations in ␣, ␤, and ␥ subunits. The reason for this different behavior is not clear.
The charge requirement for this position was also investigated in the ␣ subunit. Substitution of the positively charged lysine residue with arginine, another positively charged residue, with glutamine, an electrically neutral residue, or with glutamate, a negatively charged residue all had similar consequences. All substitutions resulted in a marked shift of the concentration-response curve to higher concentrations. Probably, the interaction partners of the lysine in question do not include a negatively charged residue, as additional effects would be expected in this case upon introduction of a negatively charged residue due to electrical repulsion. The decrease in the Hill coefficient upon replacement of lysine by arginine is probably due to a steric effect that occurs upon the increase of the size of the side chain.
The pentobarbital concentration dependence of the channels carrying the mutation either in the ␣ subunit or in the ␤ subunit, but not in the ␥ subunit, was clearly shifted to higher concentrations than in the wild-type channel. This is different from the results of Amin and Weiss (1993), who observed no effect on the concentration dependence of pentobarbital as a consequence of mutations altering the GABA binding pocket. It is interesting that mutations located in the same subunits affect the apparent affinity for GABA and pentobarbital. Combined with the above observations, it can be concluded that the mutations may affect channel gating at a later stage than binding of either GABA or pentobarbital. Clearly, they affect some step in common that occurs later than, but before or concomitant with, the opening of the ion channel. Ueno et al. (1997) presented data for bicuculline that are consistent with allosteric inhibition of channel opening, but only after binding of bicuculline to the GABAbinding site. This additional action that takes place after the binding of bicuculline to the GABA-binding site would be visible only in experiments using alternative means to GABA to induce opening of the channel. But other, alternative explanations of our observations are possible, although we think them unlikely. Namely, the effective mutations could alter only one of two binding sites for GABA in a way that GABA is recognized here more weakly. In addition, these mutations would allosterically inhibit channel opening by pentobarbital.
The lysine residue described here is located five and six amino acid residues, respectively, distant from the predicted entry into the transmembrane sections M2 and M3. Depending on the structure, this stretch of residues assumes that the tip of this lysine residue can be estimated to be maximally located at ϳ25 Å distance from the bilayer, assuming an extended structure of this amino acid residue stretch and a correct prediction of membrane entry, but it may be much closer to or within the bilayer. Most of the residues described so far as involved in channel gating are located within M2. But evidence has accumulated that more N-terminal and C-terminal parts of the receptor are involved in this process. In the case of the homologous glycine receptor both the M1-M2 and the M2-M3 loop (Lynch et al., 1997) and in the neuronal nicotinic acetylcholine receptor (Campos-Caro et al., 1997 ) the M3 domain seem to be implicated in the gating of the channel. For the GABA A receptor, corresponding experiments are lacking. Some information is, however, available in an abstract for the linker region between M2 and M3 (O'Shea and Harrison, 1997) . Upon mutation of the arginine residue five amino acid residues N-terminal to the one studied here to alanine, the apparent affinity of the receptor has been reported to be decreased fivefold. This residue is homologous to the residue affected in the glycine receptor that causes startle disease upon mutation to alanine (Langosch et al., 1994) . We conclude that regions outside M2 and specifically the lysine residues 278 in ␣ and 275 in ␤ subunits are involved in the conformational transduction induced by the agonist leading to the open channel.
␣ and ␤ subunits contribute nonhomologous structures to the GABA-binding site, which is thought to be located at subunit interfaces. On the other hand, gating of the channel seems to be affected by homologous amino acid residues on ␣ and ␤ subunits. The first step in channel opening is binding of GABA to its binding site. Amino acid residues F64 (Sigel et al., 1992; Smith and Olsen, 1994) and I120 (Westh-Hansen et al., 1997) on the ␣ subunit, and Y157, T160, T202, and Y205 (Amin and Weiss, 1993) on the ␤ subunit contribute to this site. Occupation of this site is then signaled through the gating structures to the ion channel. Obviously, gating has a higher symmetry than the binding of GABA. The ion channel finally is thought to be made up of all ␣, ␤, and ␥ subunits and is located in the center of the protein and therefore fully pseudosymmetrical. It will be important to characterize this transition between lower and higher degrees of symmetry.
